Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA Begins Building Pharma Industry Activity Prediction Tool
Preliminary results show INDs with End-of-Phase II meetings and other characteristics within a certain time period could become an NDA or BLA in 18 months. • Source: Shutterstock
More from US FDA
More from Agency Leadership